IO Biotech News

IO Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(8.5%)

Sep 17 21:05 ET

IO Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 11 21:06 ET

IO Biotech | 8-K: Current report

Aug 30 16:13 ET

IO Biotech | 10-Q: Q2 2024 Earnings Report

Aug 13 16:08 ET

IO Biotech | UPLOAD: Others

Aug 13 13:46 ET

IO Biotech | 8-K: IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Aug 13 07:07 ET

IO Biotech | CORRESP: CORRESP

Aug 9 13:46 ET

IO Biotech | UPLOAD: Others

Jul 30 13:46 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-10% Owner Novo Holdings A/S

Jul 26 21:24 ET

IO Biotech | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 25 21:39 ET

IO Biotech | 8-K: Current report

Jun 11 16:49 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Hunter Heidi

Jun 7 16:26 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Smith David V

Jun 7 16:26 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Hirth Peter

Jun 7 16:24 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Glaub Kathleen Sereda

Jun 7 16:22 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Elling Christian E

Jun 7 16:19 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-Director Collins Helen Louise

Jun 7 16:19 ET

IO Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(10.1%)

May 14 21:40 ET

IO Biotech | 4: Statement of changes in beneficial ownership of securities-10% Owner Novo Holdings A/S

May 14 21:15 ET

IO Biotech | 8-K: IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights

May 14 08:34 ET